These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1426 related items for PubMed ID: 25119194

  • 1. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.
    Prandoni P, Barbar S, Milan M, Campello E, Spiezia L, Piovella C, Pesavento R.
    Thromb Haemost; 2015 Jun; 113(6):1210-5. PubMed ID: 25119194
    [Abstract] [Full Text] [Related]

  • 2. The Optimal Duration of Anticoagulation in Patients with Unprovoked Venous Thromboembolism.
    Prandoni P.
    Adv Exp Med Biol; 2017 Jun; 906():89-100. PubMed ID: 27620306
    [Abstract] [Full Text] [Related]

  • 3. Optimal duration of anticoagulation in patients with unprovoked venous thromboembolism: the impact of novel anticoagulants.
    Prandoni P, Milan M, Sarolo L, Zanon E, Bilora F.
    Int Angiol; 2017 Oct; 36(5):395-401. PubMed ID: 27982558
    [Abstract] [Full Text] [Related]

  • 4. The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities.
    Prandoni P, Barbar S, Milan M, Vedovetto V, Pesavento R.
    Eur J Intern Med; 2014 Jan; 25(1):25-30. PubMed ID: 24120221
    [Abstract] [Full Text] [Related]

  • 5. Venous thromboembolism: risk factors for recurrence.
    Zhu T, Martinez I, Emmerich J.
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [Abstract] [Full Text] [Related]

  • 6. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.
    Hillis C, Crowther MA.
    Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149
    [Abstract] [Full Text] [Related]

  • 7. The optimal duration of anticoagulation in patients with venous thromboembolism: how long is long enough?
    Prandoni P, Piovella C, Spiezia L, Dalla Valle F, Pesavento R.
    Panminerva Med; 2012 Mar; 54(1):39-44. PubMed ID: 22278115
    [Abstract] [Full Text] [Related]

  • 8. Anticoagulation strategies for venous thromboembolism: moving towards a personalised approach.
    Black SA, Cohen AT.
    Thromb Haemost; 2015 Oct; 114(4):660-9. PubMed ID: 26084864
    [Abstract] [Full Text] [Related]

  • 9. Optimal duration of anticoagulation in patients with venous thromboembolism.
    Prandoni P, Piovella C, Spiezia L, Dalla Valle F, Pesavento R.
    Indian J Med Res; 2011 Jul; 134(1):15-21. PubMed ID: 21808129
    [Abstract] [Full Text] [Related]

  • 10. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
    Novacek G, Weltermann A, Sobala A, Tilg H, Petritsch W, Reinisch W, Mayer A, Haas T, Kaser A, Feichtenschlager T, Fuchssteiner H, Knoflach P, Vogelsang H, Miehsler W, Platzer R, Tillinger W, Jaritz B, Schmid A, Blaha B, Dejaco C, Eichinger S.
    Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
    [Abstract] [Full Text] [Related]

  • 11. Direct oral anticoagulants and venous thromboembolism.
    Franchini M, Mannucci PM.
    Eur Respir Rev; 2016 Sep; 25(141):295-302. PubMed ID: 27581829
    [Abstract] [Full Text] [Related]

  • 12. Management of cancer-associated venous thromboembolism - a case-based practical approach.
    Voigtlaender M, Langer F.
    Vasa; 2018 Feb; 47(2):77-89. PubMed ID: 29325495
    [Abstract] [Full Text] [Related]

  • 13. The optimal duration of anticoagulant therapy after unprovoked venous thromboembolism - still a challenging issue.
    Elmi G, Di Pasquale G, Pesavento R.
    Vasa; 2017 Mar; 46(2):87-95. PubMed ID: 28102773
    [Abstract] [Full Text] [Related]

  • 14. [The optimal duration of anticoagulant treatment following pulmonary embolism].
    Couturaud F.
    Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
    [Abstract] [Full Text] [Related]

  • 15. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.
    Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, Iotti M, Tormene D, Simioni P, Pagnan A.
    Haematologica; 2007 Feb; 92(2):199-205. PubMed ID: 17296569
    [Abstract] [Full Text] [Related]

  • 16. Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis.
    Prandoni P, Vedovetto V, Ciammaichella M, Bucherini E, Corradini S, Enea I, Cosmi B, Mumoli N, Visonà A, Barillari G, Bova C, Quintavalla R, Zanatta N, Pedrini S, Villalta S, Camporese G, Testa S, Parisi R, Becattini C, Cuppini S, Pengo V, Palareti G, Morgagni Investigators.
    Thromb Res; 2017 Jun; 154():35-41. PubMed ID: 28407492
    [Abstract] [Full Text] [Related]

  • 17. [Optimal duration of anticoagulation of venous thromboembolism].
    Savina EN, Couturaud F.
    J Mal Vasc; 2011 Dec; 36 Suppl 1():S28-32. PubMed ID: 22177766
    [Abstract] [Full Text] [Related]

  • 18. Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy.
    Zabczyk M, Plens K, Wojtowicz W, Undas A.
    Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):365-373. PubMed ID: 28062504
    [Abstract] [Full Text] [Related]

  • 19. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
    Palareti G, Legnani C, Cosmi B, Valdré L, Lunghi B, Bernardi F, Coccheri S.
    Circulation; 2003 Jul 22; 108(3):313-8. PubMed ID: 12847064
    [Abstract] [Full Text] [Related]

  • 20. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
    Palareti G, Legnani C, Cosmi B, Guazzaloca G, Pancani C, Coccheri S.
    Thromb Haemost; 2002 Jan 22; 87(1):7-12. PubMed ID: 11848459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.